MassMutual Private Wealth & Trust’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-44	Closed	-$1.4K	–	2069
2023 Q2	$1.4K	Hold	44	–	–	﹤0.01%	1573
2023 Q1	$1.07K	Hold	44	–	–	﹤0.01%	1563
2022 Q4	$1K	Hold	44	–	–	﹤0.01%	1604
2022 Q3	$1K	Hold	44	–	–	﹤0.01%	1586
2022 Q2	$1K	Hold	44	–	–	﹤0.01%	1466
2022 Q1	$2K	Buy	+44	New	+$1.28K	﹤0.01%	1228

Other funds holding CERE

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MassMutual Private Wealth & Trust's CERE Position: Q3 2023 in Review

MassMutual Private Wealth & Trust sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2023, closing a stake of 44 shares — an estimated $1.4K sold.

MassMutual Private Wealth & Trust first reported a position in CERE in Q1 2022 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 119 funds tracked by Wall St. Rank hold CERE as of Q3 2023.

MassMutual Private Wealth & Trust reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 44 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2023, an estimated $1.4K.
MassMutual Private Wealth & Trust first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
MassMutual Private Wealth & Trust's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $2K in Q1 2022.
119 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2023, filed 4 Oct 2023.